| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700254 | Clinical Oncology | 2007 | 5 Pages |
Abstract
The disease responses and durable nature of disease stabilisation seen in a proportion of our patients support the continued investigational use of this drug in the treatment of advanced soft tissue sarcomas.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Roylance, B. Seddon, A. McTiernan, K. Sykes, S. Daniels, J. Whelan,